PAG
TNYA icon

Private Advisor Group’s Tenaya Therapeutics TNYA Stock Holding History

Private Advisor Group’s Portfolio TNYA Stock Details TNYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.9K Buy
16,100
+2,000
+14% +$1.52K ﹤0.01% 2501
2026
Q1 		$9.76K Buy
+14,100
New +$10.4K ﹤0.01% 2643

Other funds holding TNYA

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EAM
Empery Asset Management New York $86.5M AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
BGM
Burkehill Global Management New York $2.77B AUM 65.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Private Advisor Group's TNYA Position: Q2 2026 in Review

Private Advisor Group increased its Tenaya Therapeutics (TNYA) stake by 14% in Q2 2026, buying an estimated $1.52K and bringing the position to 16,100 shares worth $11.9K. The position accounts for ﹤0.01% of the portfolio, ranked #2501.

Private Advisor Group first reported a position in TNYA in Q1 2026 and has held it in 2 quarters since. 101 funds tracked by Wall St. Rank hold TNYA as of Q2 2026.

  • Private Advisor Group held 16,100 shares of Tenaya Therapeutics worth $11.9K as of Q2 2026.
  • Private Advisor Group bought 2,000 Tenaya Therapeutics shares in Q2 2026, an estimated $1.52K.
  • Tenaya Therapeutics made up ﹤0.01% of Private Advisor Group's portfolio in Q2 2026, its #2501 holding.
  • Private Advisor Group first reported a position in Tenaya Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • 101 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q2 2026.

Based on Private Advisor Group's 13F filing for Q2 2026, filed 27 Jul 2026.